Study Guide - III
Livers and Spleen

1. Understand the pathophysiology of the liver and spleen. Link
2. Regarding question one, related the radiopharmaceuticals used for each organ system and identify their biopathways. Link
3. Identify the different diseases seen in liver/spleen imaging: colloidal shift and space occupying lesion. Link
4. Determine possible anatomical defects that can be seen on a liver/spleen scan (planar). Link
5. Compare the use of planar to SPECT imaging in a liver/spleen scan. Link
6. Discuss the diseases associated with hepatobiliary imaging. Link
7. Identify pharmacological augmentation used in hepatobiliary imaging. Link
8. Regarding question seven, identify controversies associated the MS and/or CCK. Link
9. Calculate: EF of the GB, dose of MS, and dose of CCK. Link
10. Determine reasons for a spleen scan.
11. Identify the process for preparing the radiopharmaceutical used in a spleen scan.
12. Identify the process for preparing sulfur colloid. Link
13. Discuss imaging procedures for: liver/spleen imaging, hepatobiliary imaging, pharmacological augmentation used in hepatobiliary imaging, and spleen imaging.
14. Compare the use of denatured labeled RBCs to those that are not denatured.
15. Part of your exam will contain hepatobiliary scenarios in which you will need to interpret what is happening or going to happen to a patient. Link Here are three examples:
    1. Prior to injecting Tc99mIDA lab results indicated that the patient had a very high bilirubin level.
    2. At 1.5 hours post IDA injection no activity is seen in the GB or small bowel. MS is administered.
    3. A 10 second bolus injection of CCK was injected into the patient to calculate the EF of the GB.

Return to the Table of Content